从SUVmax到肿瘤周长的距离:可切除非小细胞肺癌中稳健的放射组学预后生物标志物
回顾性纳入173例I-III期非小细胞肺癌患者,基于基线[18F]FDG PET/CT提取几何变量,评估其预后价值。多因素分析显示年龄、病理淋巴血管侵犯和归一化SUVmax至周长距离(nSPD)是早期复发的独立预测因素;年龄、淋巴结浸润和nSPD与短期死亡显著相关。nSCD和nSPD是优于经典PET变量的稳健预后生物标志物。
要点
- nSPD是早期复发和短期死亡的独立预测因素,aOR分别为0.02和0.03。
- SUVmean/SUVmax比值和变异系数对早期复发或短期死亡无显著预测价值。
- 除nSPD外,年龄和病理淋巴血管侵犯也是早期复发的独立预测因素。
核心结论
- 几何变量nSCD和nSPD是预测非小细胞肺癌患者最差预后的稳健生物标志物,优于经典PET变量。
研究设计与样本
- 回顾性研究,纳入173例I-III期非小细胞肺癌患者,具有基线[18F]FDG PET/CT;获取临床、组织病理学和代谢参数,肿瘤分割后提取SUV和体积变量、全局纹理、球形度以及两个新参数nSCD和nSPD。
诊断标准与关键数值
- 早期复发定义为复发患者中的早期复发,49/104例检测到早期复发;短期死亡定义为短期死亡,53例发生短期死亡;多因素分析中nSPD预测早期复发的aOR=0.02(p=0.018),预测短期死亡的aOR=0.03(p=0.022)。
临床应用与阅片要点
- 在非小细胞肺癌患者中,TNM系统单独不能解释肺癌生存差异,因此寻找预后参数至关重要;年龄、淋巴血管侵犯、淋巴结浸润和代谢几何参数可作为预后参数;通过[18F]FDG PET/CT几何变量评估的最高代谢活动点向外周位移的分级是预测最差预后的稳健生物标志物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to evaluate the prognostic value of novel geometric variables obtained from pre-treatment [18F]FDG PET/CT with respect to classical ones in patients with non-small cell lung cancer (NSCLC).
METHODS: Retrospective study including stage I-III NSCLC patients with baseline [18F]FDG PET/CT. Clinical, histopathologic, and metabolic parameters were obtained. After tumor segmentation, SUV and volume-based variables, global texture, sphericity, and two novel parameters, normalized SUVpeak to centroid distance (nSCD) and normalized SUVmax to perimeter distance (nSPD), were obtained. Early recurrence (ER) and short-term mortality (STM) were used as end points. Univariate logistic regression and multivariate logistic regression with respect to ER and STM were performed.
RESULTS: A cohort of 173 patients was selected. ER was detected in 49/104 of patients with recurrent disease. Additionally, 100 patients died and 53 had STM. Age, pathologic lymphovascular invasion, lymph nodal infiltration, TNM stage, nSCD, and nSPD were associated with ER, although only age (aOR = 1.06, p = 0.002), pathologic lymphovascular invasion (aOR = 3.40, p = 0.022), and nSPD (aOR = 0.02, p = 0.018) were significant independent predictors of ER in multivariate analysis. Age, lymph nodal infiltration, TNM stage, nSCD, and nSPD were predictors of STM. Age (aOR = 1.05, p = 0.006), lymph nodal infiltration (aOR = 2.72, p = 0.005), and nSPD (aOR = 0.03, p = 0.022) were significantly associated with STM in multivariate analysis. Coefficient of variation (COV) and SUVmean/SUVmax ratio did not show significant predictive value with respect to ER or STM.
CONCLUSION: The geometric variables, nSCD and nSPD, are robust biomarkers of the poorest outcome prediction of patients with NSCLC with respect to classical PET variables.
KEY POINTS: • In NSCLC patients, it is crucial to find prognostic parameters since TNM system alone cannot explain the variation in lung cancer survival. • Age, lymphovascular invasion, lymph nodal infiltration, and metabolic geometrical parameters were useful as prognostic parameters. • The displacement grade of the highest point of metabolic activity towards the periphery assessed by geometric variables obtained from [18F]FDG PET/CT was a robust biomarker of the poorest outcome prediction of patients with NSCLC.
引用
- Jiménez Londoño, García Vicente, Bosque, et al. SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients. Eur Radiol. 2022. PMID: 35133484. doi:10.1007/s00330-021-08523-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。